In studies conducted for the FDA approval of Xermelo, most patients saw a significant improvement in their diarrhea frequency in 12 weeks, and some patients saw results as soon as 3 weeks. Xermelo targets the overproduction of serotonin inside mNET cells to lessen carcinoid syndrome diarrhea.